The fight against cancer and other chronic diseases is fueled by advancements in medicine, and injectable cytotoxic drugs are a crucial weapon in this ongoing battle. This market, valued at USD 18.32 billion in 2022, is projected to reach a significant USD 31.24 billion by 2030, reflecting a steady Compound Annual Growth Rate (CAGR) of 6.9% over the forecast period (2023-2030). This press...